Related Experiment Video
Updated: Feb 14, 2026
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
12.3K
Dendritic cells as cancer therapeutics
Christian E Bryant1, Sarah Sutherland2, Benjamin Kong2
1Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW Australia; Dendritic Cell Research, ANZAC Research Institute, Concord, NSW Australia.
Seminars in Cell & Developmental Biology
|February 18, 2018
Summary
Dendritic cell (DC) vaccines harness T cells to fight cancer. Research is advancing DC vaccine strategies, exploring new antigens, adjuvants, and delivery methods for improved cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Cancer immune therapies show promise in controlling tumors, relying on T cell recognition.
- Dendritic cells (DCs) are crucial for initiating adaptive immune responses by presenting antigens to T cells.
- DCs are a diverse family of cells with varying functions, making them a target for anti-cancer immunity.
Purpose of the Study:
- To review the current understanding and advancements in dendritic cell (DC) vaccination for cancer immunotherapy.
- To highlight the evolution of DC vaccine strategies, including antigen loading, adjuvants, and delivery methods.
- To emphasize the development of 'second generation' DC vaccines for enhanced clinical efficacy.
Main Methods:
- Review of pre-clinical studies and early clinical trial data on DC vaccines.
- Analysis of different types of DC vaccines, including monocyte-derived and alternative blood-derived DCs.
- Examination of various tumor antigens, adjuvants, and vaccine delivery systems.
Main Results:
- DC vaccination is a logical approach to generate specific anti-tumor immunity.
- Expanding knowledge of DC subsets and their functions informs vaccine development.
- Clinical experience with DC vaccines is growing, with ongoing research into optimization.
Conclusions:
- Progress in DC biology and vaccine technology is driving the development of improved cancer immunotherapies.
- Second-generation DC vaccination strategies, potentially combined with other immunotherapies, are a priority for effective cancer treatment.
Related Concept Videos
01:23Neurons: The Cell Body and the Dendrites
7.4K
A typical nerve cell comprises three main components: the cell body, dendrites, and the axon. The cell body, also known as the soma or perikaryon, serves as the central biosynthetic hub housing a nucleus surrounded by cytoplasm containing organelles commonly found in most cells. Notably, Nissl bodies, clusters of the rough endoplasmic reticulum and free ribosomes responsible for protein synthesis, are distinctive features of the neuronal cell body. As neurons age, aggregates of a brown pigment...
7.4K
01:13Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
01:30Therapeutic Communication
8.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.8K
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
01:35Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K